Journey Medical Corporation (DERM)Healthcare | Drug Manufacturers - Specialty & Generic | Scottsdale, United States | NasdaqCM
5.39 USD
+0.22
(4.255%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 5.39 Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:51 p.m. EDT
DERM is a highly volatile stock with significant short-term price fluctuations, driven by earnings reports, analyst sentiment, and options activity. While there are positive signals from analysts and some recent product successes, the stock's negative fundamentals, high debt, and lack of dividends make it a risky short-term play. Long-term investors should be cautious due to the lack of consistent earnings and the company's financial instability. Options traders may find opportunities in the current volatility, but the risk of further declines remains high. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.179119 |
| AutoARIMA | 0.179151 |
| MSTL | 0.185246 |
| AutoTheta | 0.199202 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 22% |
| H-stat | 72.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.004 |
| Excess Kurtosis | -0.04 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 79.731 |
| Revenue per Share | 2.525 |
| Market Cap | 179,253,008 |
| Forward P/E | -89.83 |
| Beta | 1.04 |
| Profit Margins | -18.48% |
| Website | https://journeymedicalcorp.com |
As of April 11, 2026, 2:51 p.m. EDT: Options speculators are showing mixed signals. For near-term expirations, there is a concentration of open interest and volume in out-of-the-money puts, suggesting potential downside risk. However, there are also calls with high open interest, indicating some bullish sentiment. The elevated IV in certain strikes suggests uncertainty or volatility expectations. The presence of ATM anchors and top OI strikes at higher levels could indicate speculation on potential price recovery or further declines.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.18325436 |
| Address1 | 9,237 East Via de Ventura Blvd. |
| Address2 | Suite 105 |
| All Time High | 10.2 |
| All Time Low | 1.02 |
| Ask | 5.43 |
| Ask Size | 1 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 188,600 |
| Average Daily Volume3 Month | 205,237 |
| Average Volume | 205,237 |
| Average Volume10Days | 188,600 |
| Beta | 1.044 |
| Bid | 5.31 |
| Bid Size | 1 |
| Board Risk | 10 |
| Book Value | 1.173 |
| City | Scottsdale |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.39 |
| Current Ratio | 1.786 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 5.6 |
| Day Low | 5.14 |
| Debt To Equity | 79.731 |
| Earnings Call Timestamp End | 1,774,470,600 |
| Earnings Call Timestamp Start | 1,774,470,600 |
| Earnings Timestamp | 1,774,468,800 |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -3,914,000 |
| Ebitda Margins | -0.06327 |
| Enterprise To Ebitda | -37.971 |
| Enterprise To Revenue | 2.403 |
| Enterprise Value | 148,618,448 |
| Eps Forward | -0.06 |
| Eps Trailing Twelve Months | -0.47 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.0132 |
| Fifty Day Average Change | -1.6231999 |
| Fifty Day Average Change Percent | -0.23144926 |
| Fifty Two Week Change Percent | -18.325436 |
| Fifty Two Week High | 9.555 |
| Fifty Two Week High Change | -4.1650004 |
| Fifty Two Week High Change Percent | -0.43589747 |
| Fifty Two Week Low | 4.31 |
| Fifty Two Week Low Change | 1.0799999 |
| Fifty Two Week Low Change Percent | 0.25058004 |
| Fifty Two Week Range | 4.31 - 9.555 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,636,727,400,000 |
| Float Shares | 14,844,121 |
| Forward Eps | -0.06 |
| Forward P E | -89.833336 |
| Free Cashflow | -8,353,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 58 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.66174006 |
| Gross Profits | 40,934,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.31099 |
| Held Percent Institutions | 0.56245 |
| Implied Shares Outstanding | 33,256,588 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,021-11-12 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. |
| Long Name | Journey Medical Corporation |
| Market | us_market |
| Market Cap | 179,253,008 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_280596341 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -11,431,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 141,299,698 |
| Number Of Analyst Opinions | 4 |
| Open | 5.29 |
| Operating Cashflow | -12,441,000 |
| Operating Margins | -0.02755 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 480 434 6670 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 5.39 |
| Post Market Time | 1,776,456,604 |
| Previous Close | 5.17 |
| Price Hint | 2 |
| Price To Book | 4.5950556 |
| Price To Sales Trailing12 Months | 2.8978145 |
| Profit Margins | -0.18479 |
| Quick Ratio | 1.439 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.22 |
| Regular Market Change Percent | 4.25531 |
| Regular Market Day High | 5.6 |
| Regular Market Day Low | 5.14 |
| Regular Market Day Range | 5.14 - 5.6 |
| Regular Market Open | 5.29 |
| Regular Market Previous Close | 5.17 |
| Regular Market Price | 5.39 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 403,788 |
| Return On Assets | -0.05843 |
| Return On Equity | -0.44032001 |
| Revenue Growth | 0.181 |
| Revenue Per Share | 2.525 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 10 |
| Shares Outstanding | 21,330,696 |
| Shares Percent Shares Out | 0.1265 |
| Shares Short | 3,456,540 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,544,646 |
| Short Name | Journey Medical Corporation |
| Short Percent Of Float | 0.21700001 |
| Short Ratio | 11.36 |
| Source Interval | 15 |
| State | AZ |
| Symbol | DERM |
| Target High Price | 16.0 |
| Target Low Price | 11.0 |
| Target Mean Price | 13.25 |
| Target Median Price | 13.0 |
| Total Cash | 24,090,000 |
| Total Cash Per Share | 0.881 |
| Total Debt | 25,396,000 |
| Total Revenue | 61,858,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.47 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.4779 |
| Two Hundred Day Average Change | -2.0879002 |
| Two Hundred Day Average Change Percent | -0.27920943 |
| Type Disp | Equity |
| Volume | 403,788 |
| Website | https://journeymedicalcorp.com |
| Zip | 85,258 |